AKT1 and urinary bladder carcinoma: EGCG can inhibit the proliferation of pancreatic carcinoma PANC-1 cells and bladder cancer T24 and 5637 cells or promote their apoptosis through the up-regulation of PTEN expression while simultaneously suppressing the phosphorylation and expression of AKT and mTOR [38,199].